These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33605994)

  • 1. Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
    Kitabi E; Bensman TJ; Earp JC; Chilukuri DM; Smith H; Ball L; O'Shaughnessy E; Yasinskaya Y; Colangelo PM; Reynolds KS
    Clin Infect Dis; 2021 Sep; 73(5):903-906. PubMed ID: 33605994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic Study of Rectal Artesunate in Children with Severe Malaria in Africa.
    Fanello C; Hoglund RM; Lee SJ; Kayembe D; Ndjowo P; Kabedi C; Badjanga BB; Niamyim P; Tarning J; Woodrow C; Gomes M; Day NP; White NJ; Onyamboko MA
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria.
    Davis TM; Phuong HL; Ilett KF; Hung NC; Batty KT; Phuong VD; Powell SM; Thien HV; Binh TQ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):181-6. PubMed ID: 11120963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.
    Morris CA; Tan B; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5889-900. PubMed ID: 24041884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence Based Optimal Dosing of Intravenous Artesunate in Children with Severe Falciparum Malaria.
    Haghiri A; Price DJ; Fitzpatrick P; Dini S; Rajasekhar M; Fanello C; Tarning J; Watson J; White NJ; Simpson JA
    Clin Pharmacol Ther; 2023 Dec; 114(6):1304-1312. PubMed ID: 37666798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
    Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
    BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food and Drug Administration Approval of Artesunate for Severe Malaria: Enough to Achieve Best Practice?
    Thomas CM; Stauffer WM; Alpern JD
    Clin Infect Dis; 2023 Feb; 76(3):e864-e866. PubMed ID: 36056897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.
    Newton PN; Barnes KI; Smith PJ; Evans AC; Chierakul W; Ruangveerayuth R; White NJ
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1003-9. PubMed ID: 17089111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
    Kouakou YI; Tod M; Leboucher G; Lavoignat A; Bonnot G; Bienvenu AL; Picot S
    Int J Infect Dis; 2019 Dec; 89():30-44. PubMed ID: 31491558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe
    Shah PJ; Koshy J; Everett N; Attia E
    J Pharm Pract; 2020 Feb; 33(1):108-112. PubMed ID: 29898630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded Availability of Intravenous Artesunate for the Treatment of Severe Malaria in the United States.
    Rosenthal PJ; Tan KR
    Am J Trop Med Hyg; 2019 Jun; 100(6):1295-1296. PubMed ID: 30927931
    [No Abstract]   [Full Text] [Related]  

  • 14. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
    Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
    PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria.
    Bethell DB; Teja-Isavadharm P; Cao XT; Pham TT; Ta TT; Tran TN; Nguyen TT; Pham TP; Kyle D; Day NP; White NJ
    Trans R Soc Trop Med Hyg; 1997; 91(2):195-8. PubMed ID: 9196768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria.
    Batty KT; Davis TM; Thu LT; Binh TQ; Anh TK; Ilett KF
    J Chromatogr B Biomed Appl; 1996 Mar; 677(2):345-50. PubMed ID: 8704940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.
    Khanh NX; de Vries PJ; Ha LD; van Boxtel CJ; Koopmans R; Kager PA
    Antimicrob Agents Chemother; 1999 Mar; 43(3):690-2. PubMed ID: 10049291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study.
    Bélard S; Brand J; Schulze-Sturm U; Janda A; von Both U; Tacoli C; Alberer M; Kempf C; Stegemann MS; Krüger R; Varnholt V; Blohm M; Reiter K; Zoller T; Suttorp N; Mall M; von Bernuth H; Gratopp A; Hübner J; Hufnagel M; Kobbe R; Kurth F
    Pediatr Infect Dis J; 2019 Nov; 38(11):e295-e300. PubMed ID: 31626041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.